MIT Startup Exchange is pleased to announce the addition of six companies to its roster of STEX25 startups. New additions to the program include: Amogy, DeepCure, E25Bio, OPT Industries, Pathr, and Sync Computing.
DeepCure, a Boston-based A.I. drug discovery company, raised $40 million in Series A funding. Morningside Ventures led the round and was joined by investors includingTLV Partners, Sapir Venture Partners, and Benon Group